PE Investor Advent Acquires ‘Significant’ Stake in Iodine Software, Boosting Valuation to $1B

Private equity firm Advent International bought a significant stake in Iodine Software, valuing the company at more than $1 billion, Fierce Healthcare reports.

A major player in healthcare artificial intelligence, Iodine is a large clinical AI engine used by more than 800 health systems and 80,000 physicians. Its clinical AI engine improves clinical documentation to help health systems capture more revenue while also allowing providers to improve clinical care. Read more.

Total
0
Shares
Related Posts